Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Although the aetiology of rheumatoid arthritis remains unknown, there have been considerable advances in our understanding of its aetiopathogenesis in the last two decades. The role of genetic and environmental interactions in giving rise to immune dysregulation and the key cellular and cytokine mediators, as well as the signalling pathways involved, have been extensively studied. These insights have led to major advances in therapeutic options in the pharmacological management of this condition. © 2014 Elsevier Ltd. All rights reserved.

Original publication

DOI

10.1016/j.mpmed.2014.02.010

Type

Journal article

Journal

Medicine (united kingdom)

Publication Date

01/01/2014

Volume

42

Pages

227 - 230